MIR548AR

Across TCGA pan-cancer cohorts, MIR548AR RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated MIR548AR data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher MIR548AR RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR548AR expression acts as an unfavorable survival marker, although some lineages such as BLCA and MESO show a favorable association.

KIRC, BLCA, and SKCM are the cancer types where MIR548AR RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Quartile	III,IV	0.492	0.748	.001	56	view →
BLCA	DFS	Tertile	All	0.692	0.545	.006	48	view →
SKCM	DFS	Tertile	IV	0.079	0.548	.002	22	view →
MESO	OS	Median	II,III,IV	0.728	0.318	.006	18	view →
UVM	DFS	Tertile	III,IV	0.304	0.648	.007	15	view →
CESC	DFS	Median	All	0.441	0.661	.004	14	view →
UCS	DFS	Tertile	IV	0.885	0.320	.017	12	view →
LIHC	DFS	Median	III,IV	0.213	0.420	.008	12	view →
PCPG	DFS	Tertile	All	0.633	0.954	.012	9	view →
UCEC	DFS	Quartile	II,III,IV	0.841	0.704	.029	8	view →
PRAD	DFS	Quartile	All	0.660	0.856	.010	8	view →
COAD	DFS	Tertile	All	0.370	0.620	.016	7	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

MIR548AR–KIRC (DFS)

Open the KIRC breakdown →